Synthesis and biological evaluation of a nonsteroidal bromine-76-labeled androgen receptor ligand 3-[76Br]bromo-hydroxyflutamide

This publication has 39 references indexed in Scilit:

• Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP
  Oncogene, 2005
• Positron tomographic assessment of androgen receptors in prostatic carcinoma
  European Journal of Nuclear Medicine and Molecular Imaging, 2005
• Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583)
  Journal of Clinical Oncology, 2004
• Cancer Statistics, 2003
  CA: A Cancer Journal for Clinicians, 2003
• Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer
  New England Journal of Medicine, 1999
• Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
  Journal of Clinical Oncology, 1997
• The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer
  Cancer, 1995
• Prostate Specific Antigen after Gonadal Androgen Withdrawal and Deferred Flutamide Treatment
  Journal of Urology, 1995
• Synthesis of 11.beta.-[18F]Fluoro-5.alpha.-dihydrotestosterone and 11.beta.-[18F]Fluoro-19-nor-5.alpha.-dihydrotestosterone: Preparation via Halofluorination-Reduction, Receptor Binding, and Tissue Distribution
  Journal of Medicinal Chemistry, 1995
• Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer.
  Journal of Clinical Oncology, 1993